belapectin

Drug identity checked against registry records

Also recorded as GR-MD-02; galactoarabino rhamnogalacturonate

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH CirrhosisNCT04365868GALTPhase 2, Phase 3Terminated2025-03-11Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.